FDA Inspection
Kedplasma LLCKedplasma LLC – FDA Inspection, Nov 21, 2016
Record Details
This FDA Inspection record concerns Kedplasma LLC, with an inspection on November 21, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Person
- Merelynn Rhoten (Issuing Officer)
View Company Profile
ID · 18872a3b-57e9-42b1-b850-3f814376bc92
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 994704
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 606.40Suitable size, construction, etc.
- 21 CFR 606.100(b)SOPs for investigations, records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Kedplasma LLC
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 13, 2025 | Not classified | Dallas District Office | |
| April 22, 2022 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 4, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 15, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 15, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Kedplasma LLC
- FDA Inspection 1294916 - 2025-06-13
- FDA Inspection 1167877 - 2022-04-22
- FDA Inspection 902450 - 2014-11-04
- FDA Inspection 809838 - 2012-11-15
- FDA Inspection 809086 - 2012-11-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.